- DLB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
DEFA14A Filing
Dolby Laboratories (DLB) DEFA14AAdditional proxy soliciting materials
Filed: 19 Dec 22, 8:37am
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.)
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ | Definitive Proxy Statement |
☒ | Definitive Additional Materials |
☐ | Soliciting Material under §240.14a-12 |
DOLBY LABORATORIES, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☒ | No fee required |
☐ | Fee paid previously with preliminary materials |
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Your Vote Counts! | ||||||||||
|
DOLBY LABORATORIES, INC.
2023 Annual Meeting Vote by February 06, 2023 11:59 PM ET | |||||||||
| ||||||||||
| ||||||||||
You invested in DOLBY LABORATORIES, INC. and it’s time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on February 07, 2023.
Get informed before you vote
View the 10K Wrap, Notice & Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to January 24, 2023. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
*If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at www.ProxyVote.com or request a paper copy of the materials, which will contain the appropriate instructions. Please check the meeting materials for any special requirements for meeting attendance.
Vote at www.ProxyVote.com | Control # XXXX XXXX XXXX XXXX |
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. | ![]() |
Voting Items | Board Recommends | |||
1. | Election of Directors | |||
Nominees: | ||||
01 Kevin Yeaman | ![]() | |||
02 Peter Gotcher | ![]() | |||
03 Micheline Chau | ![]() | |||
04 David Dolby | ![]() | |||
05 Tony Prophet | ![]() | |||
06 Emily Rollins | ![]() | |||
07 Simon Segars | ![]() | |||
08 Anjali Sud | ![]() | |||
09 Avadis Tevanian, Jr. | ![]() | |||
2 | An advisory vote to approve Named Executive Officer compensation. | ![]() | ||
3 | Amendment and restatement of the Dolby Laboratories, Inc. 2020 Stock Plan. | ![]() | ||
4 | Amendment and restatement of the Dolby Laboratories, Inc. Employee Stock Purchase Plan. | ![]() | ||
5 | Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 29, 2023. | ![]() | ||
NOTE: In their discretion, upon such other business as may properly come before the meeting and any postponement, adjournment or continuation thereof. | ||||
|
Under New York Stock Exchange rules, brokers may vote “routine” matters at their discretion if your voting instructions are not communicated to us at least 10 days before the meeting. We will nevertheless follow your instructions, even if the broker’s discretionary vote has already been given, provided your instructions are received prior to the meeting date.
FLASHID-JOB# | 1.00000 322,224 148,294 |